Tianyin Pharmaceutical Co., Inc., which produces TCM and generic pharmaceuticals, announced final results for its 2009 fiscal year, which ended June 30, 2009. The company’s revenues rose 28% to $42.9 million, while net income climbed 32% to $7.9 million. Both numbers improved slightly on Tianyin’s forecast, which was issued with two weeks left in the fiscal year. More details...

Stock Symbol: (NYSE Amex: TPI)